Pediatric Chemotherapy and Biotherapy Provider Course Exam Study Guide

Apply it

A nurse transferring from adult oncology prepares to care for children with leukemia and brain tumors. She reviews marrow-related symptoms and neurological assessment rather than organizing her learning around the adult unit's most common epithelial cancers.

Apply it

Parents ask how their child developed leukemia when nobody in the family has cancer. Explain that changes acquired in developing cells can disrupt growth control, so an absent family history does not exclude cancer.

Apply it

A parent interprets a possible inherited predisposition as proof that every sibling will develop cancer. Clarify that susceptibility changes probability and that individualized genetic counseling determines which relatives may benefit from further assessment.

Apply it

A young survivor has no acute organ symptoms when therapy ends. The nurse explains why later growth, learning and organ assessments remain relevant as the child enters school and progresses through puberty.

Apply it

A preschool child becomes quiet and refuses drinks after treatment but cannot describe nausea. The nurse uses behavior, intake and the pediatric assessment plan to evaluate symptoms rather than waiting for an adult-style verbal description.

Apply it

An adolescent changes clinics years after childhood cancer treatment. The nurse helps transfer the treatment summary so the receiving team can plan follow-up around prior exposures, developmental timing and current health concerns.

Apply it

A hypothetical trial requires platelets of at least 75,000/µL and ANC of at least 1,000/µL. A child has platelets of 82,000/µL and ANC of 900/µL; the stated count requirements are not both met.

Apply it

A family hears that a phase 1 study offers a new treatment and assumes its benefit is already established. Explain that the study is principally learning about safety and dosing while possible benefit remains uncertain.

Apply it

A study description emphasizes the proportion of children whose tumors respond while continuing adverse-event monitoring. The nurse identifies an activity-focused phase 2 objective and avoids presenting a response signal as established superiority over standard care.

Apply it

Parents worry that assignment to a standard-treatment arm means their child will receive no cancer treatment. The nurse explains the study's comparison and identifies the active treatment described for each group in the consent materials.

Apply it

A parent asks the nurse to ensure assignment to the newer treatment because the child is very ill. Explain that randomization uses chance and that the study team cannot promise an arm based on preference.

Apply it

A family requests that a protocol-required assessment occur after treatment instead of before it. The nurse checks the study schedule and contacts the research team before assuming that the timing change is acceptable.

Apply it

A learner groups vincristine with drugs that primarily block folate metabolism. Reconstruct the distinction: vincristine disrupts spindle microtubules, whereas methotrexate interferes with folate-dependent synthesis needed for nucleotides and cell proliferation.

Apply it

A child's treatment day includes intravenous vincristine and a separately prescribed intrathecal medicine. The nurse verifies that vincristine is diluted in a flexible plastic container with the prominent intravenous-only/fatal-other-route warning, then matches it to the intravenous order and access. Finding vincristine on the intrathecal list stops the process for immediate correction.

Apply it

A nurse explains why methotrexate and vincristine are monitored differently within a multidrug regimen. Methotrexate interferes with reduced-folate availability, while vincristine disrupts spindle formation; their shared goal of controlling cancer does not erase these differences.

Apply it

After high-dose methotrexate, a child's creatinine rises and urine output falls. The nurse promptly reports the change and reviews ordered clearance monitoring because impaired elimination can extend drug exposure even after the infusion has ended.

Apply it

A methotrexate vial matches the ordered concentration, but the label identifies a preservative. The nurse withholds it from the intrathecal procedure and obtains verification of an appropriate preservative-free preparation before administration proceeds.

Apply it

A caregiver asks whether leucovorin means the methotrexate has already left the body. Explain that leucovorin supports cells through an alternate folate pathway while the team continues monitoring and supporting methotrexate elimination.

Apply it

A nurse reviewing blinatumomab links its CD19/CD3 engagement to the need for close systemic and neurological assessment. Fever with circulatory changes or new confusion prompts urgent evaluation rather than routine symptom-only treatment.

Apply it

A hypothetical order specifies 2 mg/kg for a child weighing 18 kg. The calculated amount is 36 mg before any separately prescribed modification; substituting body surface area would answer a different dosing instruction entirely.

Apply it

The current order documents a dose reduction, but the dispensed label shows the previous full dose. The nurse pauses administration and seeks reconciliation rather than assuming the label reflects a newer decision.

Apply it

Two children with similar names are receiving treatment in adjacent spaces. The nurse matches approved identifiers to the medication and administration record instead of relying on room position or familiarity with the family.

Apply it

A calendar lists treatment today, but the previous dose was delayed and given yesterday. The nurse checks the required interval and obtains clarification before administering another dose based solely on the original calendar.

Apply it

Two caregivers alternate overnight care and each believes the other gave an oral medicine. They consult the shared administration record and contact the treatment team about the unresolved dose rather than both administering it.

Apply it

A child cannot swallow an oral anticancer tablet, and a caregiver proposes crushing it on the kitchen counter. The nurse arranges pharmacy review of an appropriate administration method and the necessary handling controls.

Apply it

A nurse prepares to disconnect tubing that may release droplets. She uses the required double chemotherapy-tested gloves and resistant disposable gown, then adds eye and face protection because the planned task presents a splash risk.

Apply it

A colleague suggests omitting the protective gown because a closed transfer device is attached. The nurse retains the required protective equipment and uses the device as an additional containment measure during the handling task.

Apply it

A caregiver plans to empty a collection container after treatment without protection because it contains urine rather than a drug solution. The nurse teaches the prescribed body-fluid handling and disposal precautions for that treatment.

Apply it

A child who previously climbed stairs easily now trips and needs the handrail after vincristine treatment. The nurse assesses strength, sensation and gait and reports the functional change rather than attributing it only to inactivity.

Apply it

After vincristine, a child's stool frequency decreases and abdominal discomfort develops despite usual intake. The nurse assesses the full bowel pattern and associated symptoms, then reports the change as potentially treatment-related rather than dietary alone.

Apply it

Years after doxorubicin treatment, an adolescent reports new breathlessness during ordinary activity. The nurse highlights the prior exposure and arranges assessment rather than assuming the symptom is unrelated because cancer treatment ended long ago.

Apply it

A caregiver reports orange-red urine shortly after doxorubicin without pain or other symptoms. The nurse reviews the expected temporary color change while asking about bleeding cues and explaining which additional findings warrant prompt contact.

Apply it

A child receiving cisplatin begins turning up the television and asking classmates to repeat themselves. The nurse asks about tinnitus and hearing changes and coordinates audiological review rather than treating the behavior as simple inattention.

Apply it

During cisplatin treatment, a child's creatinine is unchanged but an ordered electrolyte result is abnormal. The nurse reports the result and assesses fluid balance rather than concluding that stable creatinine excludes treatment-related renal effects.

Apply it

A child has a white blood cell count of 2,000/µL with 20% segmented neutrophils and 5% bands. Multiplying 2,000 by 0.25 gives an ANC of 500/µL, indicating substantially reduced neutrophil availability.

Apply it

A child with low hemoglobin becomes breathless walking to the bathroom despite a normal oxygen saturation reading. The nurse assesses symptom severity and reports impaired activity tolerance rather than dismissing anemia because saturation appears reassuring.

Apply it

A thrombocytopenic child develops a sudden severe headache and unusual drowsiness. The nurse urgently escalates the neurological change rather than focusing only on the familiar bruises documented during the previous shift's assessment.

Apply it

A tube-fed child develops tender oral tissues, and a caregiver assumes brushing is unnecessary because the child is not eating. The nurse adapts gentle oral care and assesses pain and mucosal changes despite enteral feeding.

Apply it

After treatment begins for a bulky malignancy, potassium, phosphorus and uric acid rise while calcium falls. The nurse recognizes the coordinated lysis pattern and urgently reports the changes rather than addressing each result as unrelated.

Apply it

Two children start treatment, but one has bulky, highly responsive disease and impaired renal function. The nurse recognizes that this combination warrants especially close attention to the prescribed tumor lysis prevention and monitoring plan.

Apply it

A child at high lysis risk is playing comfortably when scheduled laboratory results become abnormal. The nurse promptly escalates the trend and continues ordered surveillance instead of delaying action until a change in appearance develops.

Apply it

A child with elevated uric acid has documented G6PD deficiency. The nurse withholds the prescribed rasburicase and urgently contacts the prescriber for an alternative uric acid management plan while continuing ordered tumor lysis surveillance. A normal baseline hemoglobin does not remove the contraindication because it does not establish adequate erythrocyte antioxidant protection.

Apply it

During an ifosfamide course, the administration record shows that a scheduled mesna dose was missed. The nurse promptly contacts the treatment team to correct the coverage gap under an authorized plan rather than waiting for urinary symptoms. If urinary bleeding develops despite prophylaxis, she reports it promptly and assesses the prescribed urinary and fluid-balance findings.

Apply it

A child receives the ordered hydration, but urine output declines during methotrexate monitoring. The nurse reports the response and assesses the fluid balance instead of assuming that an accurately running infusion guarantees adequate elimination.

Apply it

Before high-dose methotrexate, a child's urine output meets the ordered requirement, but urine pH is 6.5. The pH is below the label's criterion of at least 7. The nurse pauses initiation and obtains the prescribed alkalinization correction and reassessment rather than accepting adequate output as evidence that all renal safeguards are met.

Apply it

During an infusion, a child reports new burning and the nurse notices swelling near the access site. Blood return is also altered, prompting immediate recognition of possible extravasation rather than adjustment of the infusion rate.

Apply it

A child develops swelling and burning during vesicant administration. The nurse stops the infusion, leaves the access in place initially and begins aspiration and escalation under the extravasation procedure, avoiding a patency flush.

Apply it

Before a vesicant dose, expected blood return cannot be obtained although the pump runs without alarming. The nurse pauses treatment and evaluates access function rather than treating the absence of a pressure alarm as clearance to proceed.

Apply it

A child receiving blinatumomab develops fever, low blood pressure and new confusion. The nurse immediately assesses airway, breathing, circulation and neurological status, activates the emergency response appropriate to the instability, and implements the authorized infusion interruption pathway while obtaining urgent oncology assessment. The team evaluates both treatment toxicity and infection. These three findings alone do not establish a toxicity grade; full assessment determines severity and the corresponding corticosteroid, discontinuation or supervised restart plan.

Apply it

A child becomes nauseated on entering the infusion room before any medicine is given, after several difficult treatment visits. The nurse recognizes a possible conditioned response and reports the pattern for a targeted symptom plan.

Apply it

After teaching medication timing, the nurse asks a caregiver to describe tomorrow's schedule using the home record. An incorrect interval reveals a teaching gap, so the nurse clarifies the instruction and requests another explanation.

Apply it

An adolescent is scheduled to begin potentially gonadotoxic chemotherapy. The nurse raises fertility concerns early and facilitates specialist discussion before treatment, allowing the team and family to weigh available options against the urgency of cancer care.

Apply it

A school-age child misses classes during repeated treatment visits and worries about falling behind. The nurse helps the family coordinate educational support and realistic workload expectations rather than postponing all school planning until therapy ends.

Apply it

An adolescent wants messages from friends but does not want a class-wide announcement. The nurse helps the family support selected contact and discuss an acceptable explanation rather than arranging public disclosure without the adolescent's involvement.

Apply it

A sibling becomes distressed after repeated changes in childcare and little explanation of hospital visits. The nurse encourages age-appropriate information, reliable routines and opportunities for questions, while helping the family identify additional support if needed.

Apply it

A parent signs a research form, but a school-age child says nobody has explained the study. The nurse asks the research team to provide an age-appropriate discussion and address the child's questions and willingness.

Apply it

A study reports a newly recognized serious risk after a child enrolls. The nurse facilitates prompt discussion with the research team so the family can understand its relevance and reconsider continued participation through the appropriate process.

Apply it

A parent believes withdrawal is forbidden because the consent form was signed. The nurse explains the right to leave the study and connects the family with the team to discuss alternative care and a safe transition.

Apply it

A parent interprets review board approval as assurance that the experimental treatment will work. The nurse explains that oversight evaluates participant protections while the trial still investigates uncertain benefits and risks for its study population.

Apply it

After stopping an infusion for suspected extravasation, the nurse records the affected site, observed swelling and pain, suspected agent, interventions, notifications and reassessment plan, allowing the next clinician to evaluate whether the injury progresses.